1. Statistics from the American Cancer Society. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index . Accessed November 2013
2. Zeng HM, Zheng RS, Zhang SW, Zhao P, He J, Chen WQ. Trend analysis of cancer mortality in China between 1989 and 2008. Chin J Oncol, 2012, 34: 252–531
3. Nanoparticles for targeted and temporally controlled drug delivery. In: Swami A, Shi J, Gadde S, Votruba AR, Kolishetti N, Farokhzad OC, eds. Multifunctional Nanoparticles for Drug Delivery Applications: Imaging, Targeting, and Delivery (Nanostructure Science and Technology). Springer. 2012, 9–29
4. Giovanella BC, Hinz HR, Kozielski AJ, Stehlin JS, Silber R and Potmesil M. Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin. Cancer Res, 1991, 51: 3052–3055
5. Verschraegen CF, Gilbert BE, Huaringa AJ, Newman R, Harris N, Leyva FJ, Keus L, Campbell K, Nelson-Taylor T, Knight V. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res, 2004, 10: 2319–2326